Nano Medicine and Nano Safety

Malay K Das (MPharm, PhD) is a Professor of Pharmaceutics at the Department of Pharmaceutical Sciences, Dibrugarh University, India. His research interests include Novel Drug Delivery Systems, Pharmaceutical Nanotechnology, Nanomedicine, and Transdermal and Targeted Drug Delivery Systems. He has handled several major research projects sponsored by the DST, DBT, ICMR, UGC and AICTE. Professor Das has been honored with the prestigious DBT-Biotechnology Overseas Associateship at the University of South Florida, Tampa, USA and the DST-UKIERI Research Award in collaboration with the Institute of Pharmaceutical Sciences, King’s College, London. He has several publications to his credit, including peer-reviewed research and review articles in various international journals of repute, and chapters in various books for international publishers.Yashwant V Pathak (MPharm, Executive MBA, MSCM, PhD) is a Professor and the Associate Dean for Faculty Affairs at the Taneja Collegeof Pharmacy, University of South Florida, Tampa. He received his PhD from Nagpur University in India and subsequently his EMBA and MSCM (Conflict Management) from Sullivan University in Louisville, KY, USA. His extensive experience in industry and academia spans over 42 years. He has authored more than 200 publications, including peer-reviewed research papers, review articles and book chapters. In addition, he has edited more than 30 books in the areas of Nanotechnology, Drug Delivery Systems, and Nutraceuticals. He is the recipient of many international awards, including two Fulbright Fellowships. In addition to serving as series editor for Nutraceuticals: Basic Research and Clinical Applications, published by CRC Press, Dr Pathak is an Adjunct Professor at the Faculty of Pharmacy, Airlangga University, Indonesia.

• Part A: Applications of Nano Biotechnology in the development of Nano Medicine.- Chapter 1. Nanobiotechnology and its application in Nanomedicine: An Overview.- Chapter 2. Nanobiotechnology for therapeutic targeting of circulating tumor cells in the blood.- Chapter 3. Application of Nanobiotechnology in clinical diagnosis.- Chapter 4. Anti-diabetic Nano formulation from herbal source.- Chapter 5. Nanomaterials for alternative antibiotic therapy.- Part B: Nano Medicine: concept, development, clinical applications and evidences.- Chapter 6. Nano medicines and Nano drug delivery systems: trends and perspectives.- Chapter 7. Nano medicines in drug delivery from synthetic/natural sources to their clinical applications.- Chapter 8. Transdermal Nanomedicines for Reduction of Dose And Site-Specific Drug Delivery.- Chapter 9. Multifunctional mesoporous silica nanoparticles for biomedical applications.- Chapter 10. Advances in pulmonary Nano medicine for therapeutic management of respiratory diseases.- Chapter 11. Nanoemulsion Delivery of Herbal Products: Prospects and Challenges.- Chapter 12. Stimuli-responsive polymers for cancer Nano medicines.- Chapter 13. Carbohydrate-Derived Tailorable Interfaces: Recent Advances and Applications.- Chapter 14. Multifunctional Nano scale particles for theranostic application in healthcare.- Chapter 15. Ligand nanoparticle conjugation approach for targeted cancer chemotherapy.- Chapter 16. Tunable Biopolymeric Drug Carrier Nanovehicles and Their Safety.- Chapter 17. Nano medicine for challenging solid tumors: Recent trends and future ahead.- Part C: Regulatory, safety and marketing aspects of Nano Medicine.- Chapter 18. Recent trends for Nano medicine safety.- Chapter 19. Nano toxicity and risk assessment of Nano medicines.- Chapter 20. Clinical toxicity of Nano medicines.- Chapter 21. Nano Medicine: Risk, Regulation, Safety and Public Health.- Chapter 22. New deliveries and nanomedicines: Commercial aspects and business perspectives.- Chapter 23. Global growth of Nano medicines and what role it will play for economically weak countries.